NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
Key Highlights
- ➤NeOnc (NTHI) scheduled for Fox Business appearance October 25 at 5:30 p.m. ET
- ➤Abu Dhabi Department of Health MOU covers CNS cancer research and potential future clinical studies
- ➤NEO100 Compassionate Care patient reportedly breathing independently and moving legs after treatment began
- ➤NEO100 is designed for non-invasive brain delivery without surgery or systemic chemotherapy
- ➤CEO Amir F. Heshmatpour said NeOnc could significantly impact brain cancer standard of care
Expert Statements
Amir F. Heshmatpour, CEO of NeOnc Technologies Holdings
“We believe that we will make a significant impact in the standard of care for adults and kids suffering with brain cancer.”
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ: NTHI) is taking its brain cancer research story to a national television audience at a moment when several developments are putting the clinical-stage biotech in the spotlight. The company is scheduled to appear on Health Uncensored with Dr. Drew on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET, following a series of milestones involving its investigational brain tumor therapies and growing presence in Abu Dhabi.
CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc’s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The company’s intranasal candidate, NEO100, is designed to provide a non-invasive route for delivering therapy to the brain without relying on surgery or systemic chemotherapy as the delivery method.
Get started
Create a free account to read the full story.